TY - JOUR T1 - Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal JO - PharmacoEconomics UR - http://eprints.whiterose.ac.uk/114663/ PY - 2017/05/01 AU - Carroll C AU - Tappenden P AU - Rafia R AU - Hamilton J AU - Chambers D AU - Clowes M AU - Durrington P AU - Qureshi N AU - Wierzbicki AS ED - DO - DOI: 10.1007/s40273-017-0492-6 VL - 35 IS - 5 SP - 537 EP - 547 Y2 - 2025/06/24 ER -